Literature DB >> 10427607

Dimensional structure of psychotic symptoms: an item-level analysis of SAPS and SANS symptoms in psychotic disorders.

V Peralta1, M J Cuesta.   

Abstract

The factor structure of psychotic symptoms as assessed by means of the Scales for the Assessment of Positive and Negative Symptoms (SAPS and SANS) was examined in a sample of 660 psychotic inpatients. Analyses were conducted at item-level. Principal-component analysis (PCA) was used to extract factors, the OBLIMIN procedure to rotate factors, and the eigen value greater-than-one criterion to determine the number of factors. PCA resulted in 11 interpretable factors explaining 64% of the total variance: poverty of affect/speech, thought disorder/inappropriate affect, bizarre delusions, social dysfunction, other delusions, paranoid delusions, bizarre behavior, nonauditory hallucinations, auditory hallucinations, manic thought disorder, and attention. Many of the factors were significantly intercorrelated. A second-order PCA resulted in four second-order factors, the first three roughly corresponding to the well-known psychosis, disorganization and negative dimensions. It is concluded that the factor structure of psychotic symptoms is more complex than is generally acknowledged, and that the dimensions of psychosis, disorganization and negative represent second-order dimensions. The subscale composition of the SAPS and SANS was not supported.

Entities:  

Mesh:

Year:  1999        PMID: 10427607     DOI: 10.1016/s0920-9964(99)00003-1

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  57 in total

Review 1.  Categorical vs dimensional classifications of psychotic disorders.

Authors:  Melissa Potuzak; Caitlin Ravichandran; Kathryn E Lewandowski; Dost Ongür; Bruce M Cohen
Journal:  Compr Psychiatry       Date:  2012-06-07       Impact factor: 3.735

2.  Disorganization and reality distortion in schizophrenia: a meta-analysis of the relationship between positive symptoms and neurocognitive deficits.

Authors:  Joseph Ventura; April D Thames; Rachel C Wood; Lisa H Guzik; Gerhard S Hellemann
Journal:  Schizophr Res       Date:  2010-06-25       Impact factor: 4.939

Review 3.  Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions.

Authors:  Deanna M Barch; Erin C Dowd
Journal:  Schizophr Bull       Date:  2010-06-21       Impact factor: 9.306

Review 4.  Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research.

Authors:  Julie W Messinger; Fabien Trémeau; Daniel Antonius; Erika Mendelsohn; Vasthie Prudent; Arielle D Stanford; Dolores Malaspina
Journal:  Clin Psychol Rev       Date:  2010-09-18

Review 5.  The structure of negative symptoms within schizophrenia: implications for assessment.

Authors:  Jack J Blanchard; Alex S Cohen
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

Review 6.  Psychological pathways to depression in schizophrenia: studies in acute psychosis, post psychotic depression and auditory hallucinations.

Authors:  Max Birchwood; Zaffer Iqbal; Rachel Upthegrove
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-06       Impact factor: 5.270

Review 7.  Persistent negative symptoms in schizophrenia: an overview.

Authors:  Robert W Buchanan
Journal:  Schizophr Bull       Date:  2006-11-10       Impact factor: 9.306

8.  Pupillometric measures of attentional allocation to target and mask processing on the backward masking task in schizophrenia.

Authors:  Eric Granholm; Scott C Fish; Steven P Verney
Journal:  Psychophysiology       Date:  2009-05       Impact factor: 4.016

Review 9.  Seeking verisimilitude in a class: a systematic review of evidence that the criterial clinical symptoms of schizophrenia are taxonic.

Authors:  Richard J Linscott; Judith Allardyce; Jim van Os
Journal:  Schizophr Bull       Date:  2009-01-27       Impact factor: 9.306

10.  The latent structure of psychiatric symptoms across mental disorders as measured with the PANSS and BPRS-18.

Authors:  Richard A Van Dorn; Sarah L Desmarais; Kevin J Grimm; Stephen J Tueller; Kiersten L Johnson; Brian G Sellers; Marvin S Swartz
Journal:  Psychiatry Res       Date:  2016-08-09       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.